Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 55 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 8318666

    Use of leptin to treat metabolic abnormalities associated with lipoatrophy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  2. US 8313789

    Methods of promoting the growth of beneficial bacteria in the gut

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  3. US 8309527

    Immunomodulatory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted

  4. US 8303960

    Radiolabeled affibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  5. US 8299050

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  6. US 8298541

    Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  7. US 8293800

    Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  8. US 8293724

    Therapeutic applications of fatty acid amide hydrolase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  9. US 8287857

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  10. US 8288530

    Method of preparing macromolecular contrast agents and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  11. US 8288439

    Methods and compositions for the inhibition of HIV-1 replication

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  12. US 8283151

    Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  13. US 8278246

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  14. US 8278458

    Desferrithiocin polyether analogues

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  15. US 8278272

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  16. US 8273724

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  17. US 8268602

    Cellular and viral inactivation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  18. US 8268890

    Method of treating ischemia/reperfusion injury with nitroxyl donors

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  19. US 8268894

    Compositions and methods for the treatment of infectious diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  20. US 8263759

    Sets of probes and primers for the diagnosis of select cancers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  21. US 8258106

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  22. US 8258278

    Methods and compositions for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  23. US 8252545

    Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  24. US 8252845

    Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.